[1] 曹毅,马娜. CD90在肝细胞肝癌组织中的表达及其与病理相关性研究. 肝脏, 2017, 22:241-244. [2] Clark T, Maximin S, Meier J, et al. Hepatocellular carcinoma: review of epidemiology, screening, imaging diagnosis, response assessment, and treatment. Curr Probl Diagn Radiol,2015, 44:479-486. [3] 郝磊,郝坤. 血清AFP、AFU、CEA、GP73及糖链抗原系列联合检测对于早期原发性肝癌的诊断价值. 实用癌症杂志, 2017, 32:1609-1612. [4] 李勇,宋琦炜. 肝硬化背景下超声造影鉴别诊断肝细胞肝癌和血管瘤的价值分析. 肝脏, 2017, 22:1032-1035. [5] 胥冬冬. 肝脏增强CT检查与肝脏MRI检查在诊断肝癌方面的准确率对比. 当代医药论丛, 2015, 13:35-36. [6] Lu LH, Zhang YF, Wei W, et al. Preoperative Carbohydrate Antigen 19-9: Its Neglected Role in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients. J Gastrointest Surg, 2017,21:2025-2032. [7] Conte A, Pierantoni GM. Update on the Regulation of HIPK1, HIPK2 and HIPK3 Protein Kinases by microRNAs . Microrna, 2018,7:178-186. [8] Qian YY, Li K, Liu QY, et al.Long non-coding RNA PTENP1 interacts with miR-193a-3p to suppress cell migration and invasion through the PTEN pathway in hepatocellular carcinoma. Oncotarget, 2017, 8:107859-107869. [9] 刘宁,孙鹤鸣,赵怡雯,等. 转化生长因子β上调肝癌中GP73表达的分子机制. 生物技术通讯, 2018, 29:636-640. [10] 游蓥琳. 血清甲胎蛋白、甲胎蛋白异质体与高尔基体蛋白73检测在原发性肝癌诊断中的临床价值. 临床合理用药杂志, 2018, 11:140-142. |